InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: Theo post# 269320

Monday, 10/17/2016 11:15:24 AM

Monday, October 17, 2016 11:15:24 AM

Post# of 286050
Experienced regulatory help seems to be equally weighted with R & D, especially with this FDA regime. We've seen a lot of Bios with iffy science have tremendous runs because some co.s are good at working the committees.


Can't find much on Carrie-Lynn Langlais Furr, ok I really wanted to check her Linkedin profile to see if she was babelicious...I assume that might help as well...why not? Still with a small position and not whining yet, but they've made this move for a reason and apparently it wasn't to pump the pps as evidenced by market reaction this morning.

Profile Not Found | LinkedIn
https://www.linkedin.com/pub/carrie-lynn-langlais-furr-phd-rac/14/a38/226

Carrie Lynn Langlais Furr PhD RAC | | Email Program Manager | @ | Phone:
http://www.joesdata.com/executive/Carrie_Lynn_Langlais_Furr_PhD_RAC_2365783096.html
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.